Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Biotech Stocks Facing FDA Decision In January 2024

Por: RTTNews Health December 28, 2023

thumbnail

As the year draws to a close, it's time to assess the current status regarding the approval of novel drugs, also referred to as new molecular entities.The highest number of novel drugs was approved in 2018 - with 59 getting the FDA nod, and this record still remains unbeaten.As of this writing, 55 novel drugs have been greenlighted by the U.S. regulatory agency this year, making it the second-highest tally. This number compares favorably... + full article



Similar News

Biotech stocks set for a rebound in 2024, analysts say

MarketWatch USA Politics December 24, 2023

thumbnailThat would give investors some welcome relief after three tough years for the sector. In the wake of steep declines in 2021 and 2022, the SPDR S&P Biotech exchange-traded fund is up 5.5% so far this year but still lags far behind the S&P 500’s 24% gain. A boom in biotech... + más

High school scores and top performers from Friday, March 24 | Orlando Sentinel

High school scores and top performers from Tuesday, March 28 | Orlando Sentinel


Drug to extend dog lives receives encouraging news

Newsweek USA Nation November 29, 2023

thumbnailA California biotech company that's pioneering a drug aiming to extend the lifespan of dogs said it cleared a vital hurdle, as the medication gained a portion of conditional approval by the U.S. Food and Drug Administration (FDA).Loyal, a San Francisco-based company founded... + más

New Mexico Better Newspaper Contest Winners | Associated Press

What America Could Look Like Without Fox News | Time


US health system will go 'bankrupt' in 'a few years,' biotech entrepreneur warns

Fox Business USA Tech April 06, 2023

thumbnailGraviton Chairman and CEO Sam Waksal joined ‘Mornings with Maria’ to discuss the recent ‘implosion’ in the biotech sector and the country's latest efforts to fuel Alzheimer’s research. One biotech leader is sounding the alarm on a dire problem faced by the health... + más

Did Martha Washington really name a cat after Alexander Hamilton? | The Boston Globe

'Frustration' fuels Broncos' sideline blowup in loss | ESPN


Daydream Believers: Read This Before You Invest In AI

Forbes USA Business March 04, 2023

thumbnailAI is going from red hot to white hot. Is that hot enough to burn investors? Pitchbook notes that venture capital investment in generative AI like ChatGPT is up 425% since 2020, from $500 million to more than $2.1 billion. The global VC industry is plunked into AI. Roughly 40%... + más

What 'Moonage Daydream' Teaches Us About David Bowie | Time

‘Moonage Daydream’ celebrates David Bowie and his many ch-ch-ch-ch-changes | The Boston Globe


Boston biotech internship program aims to increase diversity through expansion

The Boston Globe USA Business February 06, 2023

thumbnailWhen Betelihem Alemayehu moved with her parents from the countryside of Ethiopia to Boston nearly a decade ago, she didn’t know how to ride the T, she couldn’t speak English, and she could never have guessed that one day she’d be employed in one of the city’s... + más

Wall Street internship checklist: How to land a competitive 2024 summer job in investment banking, trading, or asset management | Business Insider

‘Holding on by its fingernails.’ The biotech industry in Massachusetts braces for another tough year. | The Boston Globe


‘Holding on by its fingernails.’ The biotech industry in Massachusetts braces for another tough year.

The Boston Globe USA Business January 21, 2023

thumbnailIt’s hard to overstate the Boston biotechnology industry’s astronomical growth, which has overflowed from its longtime stronghold of Kendall Square in Cambridge into the Fenway, Seaport, and surrounding suburbs. But by most financial measures, 2022 was a terrible, horrible,... + más

NFL Week 4: Across the league, teams have hit the ground running this year | The Boston Globe

Boston biotech internship program aims to increase diversity through expansion | The Boston Globe


What we know about the new COVID-19 variant XBB

The Boston Globe USA Nation December 29, 2022

thumbnailA new coronavirus variant dubbed XBB has swiftly spreading in the Northeast, jumping from about 35 percent of cases during the week ending Dec. 17 to just over half of cases last week, according to .Here’s a quick primer on what we know about the variant.It is more... + más

Highly Immune Evasive Omicron XBB.1.5 Variant Is Quickly Becoming Dominant in U.S. as It Doubles Weekly | NBC 6 South Florida

Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly | CNBC



About iurex | Privacy Policy | Disclaimer |